Project 5 - Cardiovascular Systems Area
项目5-心血管系统领域
基本信息
- 批准号:8883607
- 负责人:
- 金额:$ 25.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAgingAnastomosis - actionAntibodiesAntigensAreaBlocking AntibodiesBlood PressureBlood VesselsBlood capillariesCardiovascular systemCell ProliferationCharacteristicsChondroitin Sulfate ProteoglycanComplexComputer SimulationDataDevelopmentDiseaseEndothelial CellsGenetic ModelsGoalsGrowthHarvestHypertensionInbred SHR RatsInstructionLabelLengthLocationMeasuresMentorsMesenteryMethodsMicrocirculationMicrovascular DysfunctionModelingMolecularMuscleNeurogliaNeuronsPathway interactionsPatternPericytesRegenerative MedicineResearchResistanceStructureTestingTimeTissue HarvestingTissuesVenousWorkage relatedangiogenesisarteriolebasecapillarycell motilitycomputational network modelingdensitydesigngain of functionhemodynamicsinsightnetwork architecturenetwork modelsnormotensivenovelrestorationvenule
项目摘要
Microvascular rarefaction, defined by the anatomical loss of microvessels, is a common characteristic of
hypertension. Because the loss of vessels accompanies elevated blood pressure therapies aimed at
reversing rarefaction represent candidate treatments for the disease. However, the development of such
therapies requires an understanding of the functional relationship between network patterns and
microvascular resistance over the time course of aging and the identification of the molecular players
responsible for the impaired network growth. Recent data by the PI suggests that microvascular networks in
the adult spontaneously hypertensive rat have increased arterial/venous anastomoses indicating that
rarefaction is more complex that just a loss of vessels. We also have observed reduced perivascular cell
expression of Neuron-Glia Antigen 2 (NG2), a chondroitin sulfate proteoglycan functionally involved in
angiogenesis. NG2 is a positive regulator of endothelial cell proliferation and migration and directly
influences the number of vessels present. Our observations suggest a novel molecular meachanism for
microvascular rarefaction during hypertension. We hypothesize that reduced NG2 expression in
hypertensive microvascular networks results in altered architectural patterns leading to elevated
microvascular resistance. In order to test this hypothesis, we will complete the following specific aims using
the spontaneously hypertensive rat model:
AIM 1: Determine the microvascular network architecture and NG2 expression alterations over the time
course of aging in spontaneously hypertensive rats.
AIM 2: Establish that NG2 inhibition is sufficient to alter microvascular network architectures.
AIM 3: Use a computational model to quantitatively determine the effect of altered hypertensive
microvascular network architectures on microvascular network resistance.
The results from this work will set new directions for investigating the relationships between microvascular
structure and elevated microvasuclar resistance in hypertension.
微血管损失定义的微血管罕见,是微血管的解剖学损失,是
高血压。因为血压丧失伴随着针对的血压疗法
逆转稀疏代表了该疾病的候选治疗方法。但是,这种发展
疗法需要了解网络模式与
在衰老的时间过程中的微血管抗性和分子玩家的鉴定
负责网络增长受损。 PI的最新数据表明,微血管网络
成年自发性高血压大鼠的动脉/静脉吻合术增加,表明
稀疏更为复杂,而仅仅是容器的损失。我们还观察到血管周细胞减少
神经元-GLIA抗原2(NG2)的表达,硫酸软骨素蛋白聚糖在功能上参与
血管生成。 NG2是内皮细胞增殖和迁移的积极调节剂,直接
影响存在的船只数量。我们的观察结果表明了一种新颖的分子摩卡
高血压期间的微血管稀疏。我们假设降低的NG2表达
高血压微血管网络导致建筑模式改变,导致升高
微血管抗性。为了检验这一假设,我们将使用
自发性高血压大鼠模型:
AIM 1:确定微血管网络架构和NG2表达变化
自发性高血压大鼠衰老的过程。
目标2:确定NG2抑制作用足以改变微血管网络体系结构。
AIM 3:使用计算模型定量确定高血压改变的影响
微血管网络电阻的微血管网络体系结构。
这项工作的结果将为研究微血管之间的关系设定新的方向
高血压中的结构和升高的微伏脉抗性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WALTER L MURFEE其他文献
WALTER L MURFEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WALTER L MURFEE', 18)}}的其他基金
Bioengineering Approach for Advancing Reparative Medicine Stem Cell Technologies
推进修复医学干细胞技术的生物工程方法
- 批准号:
10673032 - 财政年份:2022
- 资助金额:
$ 25.51万 - 项目类别:
Bioengineering Approach for Advancing Reparative Medicine Stem Cell Technologies
推进修复医学干细胞技术的生物工程方法
- 批准号:
10451968 - 财政年份:2022
- 资助金额:
$ 25.51万 - 项目类别:
EFFECT OF MICROVASCULAR PATTERNING ALTERATIONS ON NETWORK RESISTANCE IN SPONTANE
微血管模式改变对自发网络阻力的影响
- 批准号:
8360260 - 财政年份:2011
- 资助金额:
$ 25.51万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 25.51万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 25.51万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 25.51万 - 项目类别:
Age and hearing loss effects on subcortical neural encoding
年龄和听力损失对皮层下神经编码的影响
- 批准号:
10652139 - 财政年份:2023
- 资助金额:
$ 25.51万 - 项目类别: